NWT‐02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk and reduction of the loss of vision: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Nutrition and Allergies EFSA Panel on Dietetic Products,Dominique Turck,Jean‐Louis Bresson,Barbara Burlingame,Tara Dean,Susan Fairweather‐Tait,Marina Heinonen,Karen Ildico Hirsch‐Ernst,Inge Mangelsdorf,Harry J McArdle,Androniki Naska,Monika Neuhäuser‐Berthold,Grażyna Nowicka,Kristina Pentieva,Yolanda Sanz,Anders Sjödin,Martin Stern,Daniel Tomé,Henk Van Loveren,Marco Vinceti,Peter Willatts,Ambroise Martin,Sean Strain,Alfonso Siani,,Sean (J.J.) Strain
DOI: https://doi.org/10.2903/j.efsa.2018.5139
2018-01-01
EFSA Journal
Abstract:Following an application from Newtricious R&D B.V., submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of the Netherlands, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to NWT-02 and a reduction of the loss of vision. The food proposed by the applicant as the subject of the health claim is NWT-02. NWT-02 is standardised by its content in lutein (≥ 1.10 mg), zeaxanthin (≥ 0.20 mg) and docosahexaenoic acid (DHA) (≥ 170 mg). The Panel considers that the food/constituent that is the subject of the health claim, NWT-02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk, is sufficiently characterised. The claimed effect proposed by the applicant is 'reduces loss of vision'. The target population proposed by the applicant is 'healthy adults over 50 years of age'. The Panel considers that a reduction of the loss of vision is a beneficial physiological effect. The applicant provided two human intervention studies for the scientific substantiation of the claim. The Panel considers that the only study from which conclusions can be drawn for the scientific substantiation of the claim did not show an effect of NWT-02 on vision. The Panel concludes that a cause and effect relationship has not been established between the consumption of NWT-02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk, and a reduction of the loss of vision.
food science & technology